drugset / Trial / NCT03832400
Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)
RandomizedParallel-groupSingle-blindTreatment
Summary
To define the parameters for dose-dependent engraftment of MET-2 commensal bacteria for the treatment of mild to moderate ulcerative colitis
Timeline
- Start
- 2019-02-04
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MET-2 | Other / unclassified | 1.5 g | Oral |